BioNTech SE (BNTX) Operating Expenses (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Operating Expenses data on file, last reported at -$784.6 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 1.61% year-over-year to -$784.6 million; the trailing twelve-month figure through Dec 2025 stood at -$3.0 billion (up 1.74% YoY), and the FY2025 full-year result was -$3.0 billion, up 0.57% from the prior year.
• Operating Expenses grew to -$784.6 million in Q4 2025, from -$802.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$299.7 million in Q2 2021 to a low of -$813.6 million in Q2 2024.
• A 5-year average of -$600.6 million and a median of -$653.9 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses tumbled 131816999.25% in 2021 and climbed 12.79% in 2025, its largest moves.
• Tracing BNTX's Operating Expenses over 5 years: stood at -$460.3 million in 2021, then tumbled by 39.56% to -$642.4 million in 2022, then slipped by 17.58% to -$755.4 million in 2023, then retreated by 2.22% to -$772.2 million in 2024, then declined by 1.61% to -$784.6 million in 2025.
• Business Quant data shows BNTX's Operating Expenses at -$784.6 million in Q4 2025, -$802.0 million in Q3 2025, and -$709.5 million in Q2 2025.